Cargando…
Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor
NRH:Quinone Oxidoreductase 2 (NQO2) has been described as having no enzymatic activity with nicotinamide adenine dinucleotide (NADH) or NADPH as electron donating cosubstrates. Mitomycin C (MMC) is both a substrate for and a mechanistic inhibitor of the NQO2 homologue NQO1. NRH:quinone oxidoreductas...
Autores principales: | Jamieson, D, Tung, A T Y, Knox, R J, Boddy, A V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360572/ https://www.ncbi.nlm.nih.gov/pubmed/17031400 http://dx.doi.org/10.1038/sj.bjc.6603414 |
Ejemplares similares
-
3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors
por: Lozinskaya, Natalia A., et al.
Publicado: (2023) -
NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
por: Lee, Junguee, et al.
Publicado: (2013) -
Reduction and
Scavenging of Chemically Reactive Drug
Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase
2 and Variability in Hepatic Concentrations
por: den Braver-Sewradj, Shalenie P., et al.
Publicado: (2017) -
Curcumol Overcomes TRAIL Resistance of Non‐Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2)
por: Zhang, Jing, et al.
Publicado: (2020) -
Association Between a Tri-allelic Polymorphism in the Estrogen Metabolism Oxidoreductase NRH:Quinone Oxidoreductase 2 Gene and Risk of Breast Cancer by Molecular Subtype
por: Zhou, Jiao-Qun, et al.
Publicado: (2021)